Efficacy of Nitric Oxide in Stroke Trial "ENOS"


Phase 3 Results N/A

Summary of Purpose

To assess the risks and benefits of administering transdermal nitrous oxide immediately after ischemic and hemorrhagic stroke, and to determine whether or not to continue anti-hypertensive medication taken prior to stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 2 March 2010.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics



  • BUPA Foundation; The Hypertension Trust, University of Nottingham, Medical Research Council.

Trial Design

Prospective, international, multicenter, randomized, controlled, parallel-group, single-blind, collaborative trial.


  • Sally Utton ENOS Trial Manager Division of Stroke Medicine The University of Nottingham Clinical Sciences Building Nottingham City Hospital Nottingham NG5 1PB www.enos.ac.uk Tel: +44 (0) 115 823 0287 Fax: +44 (0) 115 823 1771